Literature DB >> 16427108

Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag.

S J Rulli1, D Muriaux, K Nagashima, J Mirro, M Oshima, J G Baumann, A Rein.   

Abstract

We have investigated the properties of murine leukemia virus Gag mutants in which the p12-CA cleavage site is altered. In one mutant, the cleavage is blocked; in the other, the conserved proline at the N-terminus of CA has been replaced with glycine. No infectivity was detected in either mutant. Mutant particles cannot synthesize full-length DNA upon infecting permissive cells. Particles composed of a mixture of wild-type and mutant proteins have severely impaired infectivity. These mixed particles are defective in their ability to synthesize DNA upon infection, but this defect is less severe than the loss of infectivity. Thus, proteins lacking the correct N-terminus of CA inhibit DNA synthesis and also interfere with formation or integration of a full-length, normal provirus. The results imply that CA proteins function as part of a large, highly organized structure in reverse transcription and apparently at a later step as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16427108     DOI: 10.1016/j.virol.2005.12.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.

Authors:  Cristina Gherghe; Tania Lombo; Christopher W Leonard; Siddhartha A K Datta; Julian W Bess; Robert J Gorelick; Alan Rein; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly.

Authors:  John G Purdy; John M Flanagan; Ira J Ropson; Kristen E Rennoll-Bankert; Rebecca C Craven
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

Review 3.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

4.  An immature retroviral RNA genome resembles a kinetically trapped intermediate state.

Authors:  Jacob K Grohman; Robert J Gorelick; Sumith Kottegoda; Nancy L Allbritton; Alan Rein; Kevin M Weeks
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability.

Authors:  Jiyang Jiang; Sherimay D Ablan; Suchitra Derebail; Kamil Hercík; Ferri Soheilian; James A Thomas; Shixing Tang; Indira Hewlett; Kunio Nagashima; Robert J Gorelick; Eric O Freed; Judith G Levin
Journal:  Virology       Date:  2011-10-26       Impact factor: 3.616

6.  A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

Authors:  Shixing Tang; Sherimay Ablan; Megan Dueck; Wilfredo Ayala-López; Brenda Soto; Margaret Caplan; Kunio Nagashima; Indira K Hewlett; Eric O Freed; Judith G Levin
Journal:  Virology       Date:  2006-10-19       Impact factor: 3.616

7.  A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle.

Authors:  Sook-Kyung Lee; Janera Harris; Ronald Swanstrom
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

9.  Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.

Authors:  Marcy R Auerbach; Kristy R Brown; Ila R Singh
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

10.  Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.

Authors:  Samuel J Rulli; Jane Mirro; Shawn A Hill; Patricia Lloyd; Robert J Gorelick; John M Coffin; David Derse; Alan Rein
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.